[1]Wanqing Chen，Rongshou Zheng，Peter D Baade，et al.Cancer statistics in China，2015［J］.CA Cancer J Clin，2016，66(2)：115-132.
[2]Rebecca L Siegel，Kimberly D Miller，Ahmedin Jemal DVM.Cancer statistics，2018［J］.CA Cancer J Clin，2018，68(1)：7-30.
[3]Sporn MB，Dunlop NM，Newton DL，et al.Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs（retinoids)［J］.Fed Proc，1976，35(6)：1332-1338.
[4]Yao R，Wang Y，Lubet RA，et al.Differential gene expression in chemically induced mouse lung adenomas［J］.Neoplasia，2003，5(1)：41-52.
[5]Feng QX, Huang JX, Wei SL.Prevention effect of EGCG in rats lung cancer induced by benzopyrene［J］.Chin J Cancer Pre Treat, 2012,19(6):415-418.
[6]Wang CK，Chang LW，Chang H，et al.Pulmonary changes induced by trans，trans-2，4-decadienal，a component of cooking oil fumes［J］.Eur Respir J，2010，35(3)：667-675.
[7]Raphael N，Meyer AM，Hudish TM，et al.Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator-activated receptor gamma［J］.Cancer Prev Ｒes，2008，1(5)：349-356.
[8]Tian JH，Yang XX，Bi L，et al.Research Jin Fukang preventive effect on D-galactose-induced aging mice model of lung cancer［J］.Chin J Cancer Biother，2016，23(1)：73-80.
[9]Liang Zongying，Zhang Le，Sun Guangrui，et al．The experimental study of coal tar pitch-induced lung cancer in SD rat［J］．J Clin Exp Med，2015，14（22)：1844-1846.［梁宗英，张乐，孙光蕊，等.煤焦油沥青烟气诱导SD大鼠肺癌动物模型的实验研究［J］.临床和实验医学杂志，2015，14(22)：1844-1846.］
[10]Ye L，He M，Huang Y，et al.Tree shrew as a new animal model for the study of lung cancer［J］.Oncol Lett，2016，11(3)：2091-2095.
[11]Yu Chenlin，Cui Shufang.Establishment and application of animal models of lung cancer［J］.ACTA Lab Animalis Scientia Sinica，2008，16(6)：470-474.［余琛琳，崔淑芳.肺癌动物模型的制备与应用［J］.中国实验动物学报，2008，16(6)：470-474.］
[12]Jakubowska M，Sniegocka M，Podgórska E，et al.Pulmonary metastases of the A549-derived lung adenocarcinoma tumors growing in nude mice.A multiple case study［J］.Acta Biochim Pol，2013，60(3)：323-330.
[13]Okada A，Shimmyo T，Hashimoto T，et al.Predictive advantage of a cell type classification for pulmonary adenocarcinoma coupled with data for p53，K-ras and EGFR alterations［J］.Cancer Sci，2010，101(7)：1745-1753.
[14]Tran PT，Shroff EH，Burns TF，et al.Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis［J］.PLoS Genet，2012，8(5)：e1002650.
[15]EL Jackson，N Willis，K Mercer，et al.Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras［J］.Genes & Development，2001，15（24)：3243-3248.
[16]Li Tao，Yang Li，Wang Zhiping.Research progress on the establishment of rat bladder carcinoma in situ model［J］.J Contemp Urol Reprod Onco，2013，5(1)：51-53.［李涛，杨立，王志平.鼠膀胱癌原位模型建立的研究进展［J］.现代泌尿生殖肿瘤杂志，2013，5(1)：51-53.］
[17]Man K，Ng KT，Lo CM，et al.Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases-activation of cell invasion and migration pathways［J］.Liver Transpl，2007，13(12)：1669-1677.
[18]Li Jing，Wang Xuefei，Zhong Mei.Establishment of whole-body visualization models of ovarian cancer orthotopic and metastatic model in nude mice［J］.Guangdong Med J，2012，33(7)：887-889.［黎静，王雪飞，钟梅.整体可视化卵巢癌原位及转移动物模型的建立［J］.广东医学，2012，33(7)：887-889.］
[19]Liu Xin，Wu Zhiping，Zuo Shuguang，et al.Establishment of orthotopic Lewis lung cancer model in mouse［J］.Chin J Lung Cancer，2010，13(1)：42-47.［刘馨，伍治平，左曙光，等.小鼠Lewis肺癌原位模型的构建［J］.中国肺癌杂志，2010，13(1)：42-47.］
[20]Hoffman RM.Noninvasive imaging for evaluation of the systemic delivery of capsid-modified adenovirus in an orthotopic model of advanced lung cancer［J］.Cancer，2006，107（7)：1213.
[21]Shibuya K，Komaki R，Shintani T，et al.Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer［J］.Int J Radiat Oncol Biol Phys，2007，69(5)：1534-1543.
[22]Fujino H，Kazuya Kondo，Hisashi Ishikura，et al.Matrix metalloproteinase inhibitor MMI-166 inhibits lymphogenous metastasis in an orthotopically implanted model of lung cancer［J］.Mol Cancer Ther，2005，4(9)：1409-1416.
[23]Onn A，Isobe T，Itasaka S，et al.Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice［J］.Clin Cancer Res，2003，9(15)：5532-5539.
[24]Wei Shuzhen，Sun Yu，Yang Zhijian，et al.Establishment of orthotopic lung cancer model expressing enhanced green fluorescent protein［J］.Chin J Lung Cancer，2010，13(7)：670-675.［魏淑珍，孙宇，杨志坚，等.EGFP标记的人肺癌裸鼠原位移植模型的建立［J］.中国肺癌杂志，2010，13(7)：670-675.］
[25]Wang Rong，Shu Yongqian.Metastasis-associated microRNAs in non-small cell lung cancer using fluorescent orthotopic implantationmouse modle［J］.Chin J Cancer Prev Treat，2010，17(8)：584-589.［王蓉，束永前.裸鼠荧光原位移植非小细胞肺癌模型转移相关microRNAs的研究［J］.中华肿瘤防治杂志，2010，17(8)：584-589.］
[26]Lai CW，Chen HL，Yen CC1，et al.Using dual fluorescence reporting genes to establish an in vivo imaging model of orthotopic lung adenocarcinoma in mice［J］.Mol Imaging Biol，2016 18(6)：849-859.
[27]TH March，PG Marronterada，SA Belinsky.Refinement of an orthotopic lung cancer model in the nude rat［J］.Vet Pathol，2001，38(5)：483-490.
[28]Hai J，Zhu CQ，Bandarchi B，et al.L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer［J］.Clin Cancer Res，2012，18(7)：1914-1924.
[29]Youssef G，Wallace WA，Dagleish MP，et al.Ovine pulmonary adenocarcinoma：A large animal model for human lung cancer［J］.ILAR J，2015，56(1)：99-115.
[30]Chen Yusheng，Lin Xiaofen，Li Hongru，et al.Establishment of a nude mouse model of pulmonary adenocarcinoma metastasis［J］.ACTA Laboratorium Animalis Scientia Sinica，2014，22(05)：6-7,32-34.［陈愉生，林小芬，李鸿茹，等.肺癌转移瘤动物模型的建立［J］.中国实验动物学报，2014，22(05)：6-7,32-34.］
[31]Satoh H，Moriguchi T，Taguchi K，et al.Nrf2-deficiency creates a responsive icroenvironment for metastasis to the lung［J］.Carcinogenesis，2010，31(10)：1833.
[32]Xu Yi，Tan Qunyou，Tao Shaolin，et al.Establishment and screening of lymphatic metastasis models of transplanted pulmonary adenocarcinoma in nude mice［J］.Journal of Regional Anatomy and Operative Surgery，2013，22(1)：1-3.［徐翼，谭群友，陶绍霖，等.人肺腺癌裸鼠皮下移植瘤淋巴转移模型的构建与筛选［J］.局解手术学杂志，2013，22(1)：1-3.］
[33]Zhuo Wenlei，Wang Yan，Chen Zhengtang，et al.RNAi targeting lay ilin inhib its invasion and metastasis via lymphatic vesse ls in A549 lung carcinoma cell line and its xenografts in nude mice［J］.China Oncology，2007，17(2)：110-114.［卓文磊，王彦，陈正堂，等.RNAi抑制Layilin表达对肺腺癌A549细胞体外侵袭和荷瘤鼠体内淋巴转移的影响［J］.中国癌症杂志，2007，17(2)：110-114.］
[34]Yano S，Sone S.Novel metastasis model of human lung cancer cells representing different histological types in SCID mice depleted of NK cells［J］.Gan To Kagaku Ryoho，1997，24(4)：489-494.
[35]Yang Hanze，Wang Chunyang，Chen Yue，et al.Establishment of malignant pleural effusion model of Lewis lung cancer based on micro echo technology［J］.Chin J Biochem Pharm，2017，37(2)：5-7.［杨瀚泽，王春阳，陈越，等.基于小动物超声的小鼠Lewis 肺癌胸腔积液模型的建立［J］.中国生化药物杂志，2017，37(2)：5-7.］
[36]Sonn KA，Kannan AS，Bellary SS，et al.Effect of recombinant human bone morphogenetic protein-2 on a novel lung cancer spine metastasis model in rodents［J］.J Orthop Res，2016，34(7)：1274-1281.
[37]Douglas Hanahan，Robert A Weinberg.Hallmarks of cancer：The next generation［J］.Cell，2011，144(5)：646-674.
[38]Jin Sha，Tian Jianhui.Review on immunotherapies for lung cancer［J］.Chin J Lung Cancer，2012，15(10)：606-611.［金莎，田建辉.肺癌的免疫治疗临床研究进展［J］.中国肺癌杂志，2012，15(10)：606-611.］
[39]Creelan BC.Update on immune checkpoint inhibitors in lung cancer［J］.Cancer Control，2014，21(1)：80-89.
[40]Sharpless NE，Depinho RA.The mighty mouse：Genetically engineered mouse models in cancer drug development［J］.Nat Rev Drug Discov，2006，5(9)：741-754.
[41]Ledford H.US cancer institute to overhaul tumour cell lines［J］.Nature，2016，530(7591)：391.
[42]Nakajima T，Geddie W，Anayama T，et al.Patient-derived tumor xenograft models established from samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration［J］.Lung Cancer，2015，89(2)：110-114.
[43]DeRose YS，Wang G，Lin YC，et al.Tumor grafts derived from women with breast cancer authentically reflect tumor pathology，growth，metastasis and disease outcomes［J］.Nat Med，2011，17（11)：1514-1520.
[44]Hao C，Wang L，Peng S，et al.Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer［J］.Cancer Lett，2015，357（1)：179-185.
[45]Stewart EL，Mascaux C，Pham NA，et al.Clinical utility of patient-derived xenografts to determine biomarkers of prognosis and map resistance pathways in EGFR-mutant lung adenocarcinoma［J］.J Clin Oncol，2015，33(22)：2472-2480.
[46]Tian Jianhui，Zhu Feipeng，Liu Lingshuang，et al."People-centered"therapeutic efficacy assessment criteria for Chinese medicine on solid tumor［J］.Shanghai J Traditional Chinese Medicine，2012，46(9)：3-6.［田建辉，朱飞鹏，刘苓霜，等.“以人为本”建立中医药实体瘤疗效评价标准［J］.上海中医药杂志，2012，46(9)：3-6.］
[47]Tian Jianhui，Bi Ling，Zhang Anle，et al.Establishment of an orthotopic transplant tumor model of murine lung cancer with stable expression of human IDO gene in mice［J］.Tumor，2015，35(05)：491-497.［田建辉，毕凌，张安乐，等.稳定表达人IDO 基因的小鼠肺癌原位移植瘤模型的建立［J］.肿瘤，2015，35(05)：491-497.］
[48]Gao D，Vela I，Sboner A，et al.Organoid cultures derived from patients with advanced prostate cancer［J］.Cell，2014，159(1)：176-187.
[49]Vlachogiannis G，Hedayat S，Vatsiou A，et al.Patient-derived organoids model treatment response of metastatic gastrointestinal cancers［J］.Science，2018，359(6378)：920-926.
[50]Nature Methods.Method of the Year 2017：Organoids［J］.Nature Methods，2018，15(1)：1.